Skip to content

Does Joint Immobilization Following Revision Total Knee Arthroplasty Improve Range of Motion Following Surgery?

Does Joint Immobilization Following Revision Total Knee Arthroplasty (rTKA) Improve Range of Motion Following Surgery?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07552415
Enrollment
170
Registered
2026-04-27
Start date
2026-08-01
Completion date
2028-04-01
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aseptic Revision Knee Arthroplasty, Stiffness Following Revision Knee Arthroplasty

Keywords

revision arthroplasty, stiffness, knee swelling

Brief summary

The goal of this study is to evaluate if knee immobilization for 10 days following revision total knee arthroplasty (rTKA) improves knee joint range of motion at 3 months postoperatively compared to standard of care postoperative protocol. Participants will be assigned to one of two groups. One group will wear a knee brace that keeps the knee straight for 10 days after surgery and will not perform knee range of motion exercises during that time. The other group will not wear a brace and will follow the standard physical therapy program, including knee range of motion exercises, starting after surgery.

Detailed description

Knee immobilization after revision total knee arthroplasty (TKA) remains unexplored in the literature despite its potential to address key challenges in the post-operative management and rehabilitation in these patients. Revision TKA is typically associated with higher rates of complications such as instability, malalignment, extensor mechanism disruption, and stiffness. Given the intricate nature of revision procedures and the increased risk of suboptimal outcomes, effective strategies for optimizing functional recovery and minimizing post-operative pain are critical. Semirigid extension bracing, a form of knee immobilization, has shown promise in primary TKA in improving pain management, promoting knee range of motion (ROM), and reducing opioid consumption. However, its role in revision TKA remains unknown. Exploring the use of knee immobilization in the revision TKA population could provide a non-pharmacological, cost-effective approach to addressing pain, minimizing complications, and improving long-term functional outcomes.

Interventions

DEVICEKnee immobilizer

Participants will wear a knee immobilizer brace for 10 days postoperatively and exclude knee range of motion exercises from postoperative physical therapy protocol during this period. They will resume all standard postoperative protocol after this period.

DEVICENo Knee Immobilizer

Participants will not wear a knee immobilizer and will perform all exercises included in postoperative physical therapy protocol.

Sponsors

Hospital for Special Surgery, New York
Lead SponsorOTHER
Orthopaedic Research and Education Foundation (OREF)
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing revision TKA for aseptic indications including aseptic loosening, polyethylene wear, instability, malalignment, periprosthetic fracture. * Patients undergoing revision TKA of one or both components.

Exclusion criteria

* Patients who are undergoing revision TKA for stiffness. * Patients with occult infection not recognized prior to revision. * Patients with hinged TKA component reconstructions. * Patients undergoing revision for liner exchange. * History of VTE/PE. * Patients on pre-operative anticoagulation. * BMI ≥ 40. * Patients with preoperative opioid use equal to or exceeding 150 Morphine Milligram Equivalents (MMEs)/day within 90 days of revision TKA.

Design outcomes

Primary

MeasureTime frameDescription
Range of motion (degrees) - knee joint; measured using digital goniometer3 months postoperativelyActive and Passive knee flexion and extension range of motion will be measured in degrees using a standardized digital goniometer at each timepoint.

Secondary

MeasureTime frameDescription
Range of motion (degrees) - knee joint; measured using a digital goniometer2 weeks, 6 weeks, and 1 year postoperativelyActive and passive knee flexion and extension will be measured in degrees using a standardized digital goniometer. Measurements will be obtained with the patient seated for flexion and supine for extension at each timepoint.
Swelling (mid-patellar circumference in centimeters) - knee joint; measured using a flexible measuring tape2 weeks, 6 weeks, 3 months and 1 year postoperativelyKnee swelling will be measured as mid-patellar circumference (cm) with knee in full extension using a standardized flexible measuring tape at each postoperative timepoint.
Stiffness - Knee Joint2 weeks, 6 weeks, 3 months, and 1 year postoperativelyIncidence of knee stiffness
Wound complications2 weeks, 6 weeks, 3 months, and 1 year postoperativelyIncidence of wound complications
Time to achieve physical therapy milestones2 weeks, 6 weeks, 3 months, and 1 year
Knee Society Scale Score Delta2 weeks, 6 weeks, 3 months, and 1 yearDelta compared to preoperative value
Functional Knee Society Scale Score Delta2 weeks, 6 weeks, 3 months, and 1 yearDelta compared to preoperative value
KOOS Jr. Score Delta2 weeks, 6 weeks, 3 months, and 1 yearDelta compared to preoperative value
PROMIS-10 Score Delta2 weeks, 6 weeks, 3 months, and 1 yearDelta compared to preoperative value
VAS Pain Score Delta2 weeks, 6 weeks, 3 months, and 1 yearDelta compared to preoperative value
Total 90 day opioid consumption90 days postoperatively

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026